VIVUS: VISX CEO and Wilson, Sonsini, Goodrich & Rosati Partner join the Vivus Board of Directors.

0 Comments | M2 Presswire, March, 1999

M2 PRESSWIRE-18 March 1999-VIVUS: VISX CEO Mark Logan and Wilson, Sonsini, Goodrich & Rosati Partner Mario Rosati join the Vivus Board of Directors (C)1994-99 M2 COMMUNICATIONS LTD RDATE:170399 MOUNTAIN VIEW, CA -- VIVUS, Inc. (Nasdaq: VVUS) has named Mark Logan, Chairman, President and Chief Executive Officer of VISX, Inc.

and Mario Rosati, a partner at Wilson, Sonsini, Goodrich & Rosati to the Company's Board of Directors. Logan and Rosati will fill the board seats vacated due to the resignations of Richard Casey and Elizabeth Fetter. All Board changes are effective immediately. Mark Logan has served as the Chairman of the Board, President and CEO of VISX, Inc., a medical device company, since 1994. From January 1992 to October 1994, he was Chairman of...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)